OVERVIEW
Clinical Research Atlanta (CRA) is a premier multi-specialty, multi-center investigative
site located in the heart of Atlanta, Georgia. Centers are located in Atlanta and
Stockbridge, Georgia.
CRA has been conducting Phase I, II, III, IV and OTC trials in children and adults since
1992. Over the past decade, CRA has conducted over 300 clinical research trials, working
with numerous pharmaceutical companies and Clinical Research Organizations.
CRA’s success can be attributed to its exceptional staff, professional management,
and effective patient recruitment tactics. CRA prides itself in providing rapid study
start-up, low staff turn over rate, which contributes to its efficient operations and
steady growth.
Tomorrow’s
Health … Today’s Agenda.
MANAGEMENT
Nathan Segall, MD, CPI
Medical Director
Michelle Sowell , CCRC
Clinical Operations Director
FACILITY DESCRIPTION
• Dedicated monitoring space for CRAs
with DSL or wireless capabilities, telephone, fax and copier.
• 6 exam rooms at each facility
• Patient lounge for extended days
• Certified On-Site Laboratory
• Pharmacokinetic studies
• IV infusion capability
• Access to radiology and ultrasound facilities
including Bone Densitometer, Mammography and MRI
• Access to Certified Endoscopy Unit with 3 suites
and recovery room (Colonoscopy & Upper Endoscopy,
Sigmoidoscopy and Liver Biopsies)
• Access to 2 Certified Sleep Labs (4 beds each)
• Access to Uroflow Machine
• Secured Drug Storage (room temperature &
refrigerated)
• Secured Storage for Study Records
• Electronic Data Capture - Done in Real Time (24
hour turnaround)
• Remote Data Capture Capabilities
• Both Sites have staff certified in LifeShirt
Training
RESEARCH EXPERIENCE
CRA has conducted Phase I-IV and OTC studies including:
• Allergy
• ADHD
• Asthma
• Anxiety
• BPH
• Pediatric Pharmacokinetics
• Common Cold
• Contraception
• Contact Dermatitis
• Depression
• Diabetes (Type 1 and 2)
• Diabetic Neuropathy
• Dyspepsia
• Chronic Obstructive Pulmonary Disease
• Erosive Esophagitis
• Exacerbation of Chronic Bronchitis
• Fatigue
• OTC Indications
• Orthopeadic
• Fibromyalgia
• GERD
• Hormone Replacement
• Hypercholesterolemia
• Hypertension (including ABPM) |
•
Incontinence
• Influenza
• Influenza Prevention
• Irritable Bowel Syndrome (IBS)
• Insomnia
• Normal Healthy
• Pediatric Growth Trials
• Metabolic Syndrome
• Migraines
• Obesity
• Onychomycosis
• Osteoarthritis
• Osteoporosis
• Overactive Bladder
• Pneumonia
• Psoriasis
• Rheumatoid Arthritis
• Rosacea
• Smoking Cessation
• Tinea Pedis
• Ulcerative Colitis
• Urinary Tract Infection
• Vaccines |
RESEARCH STAFF
• 7 Research Coordinators (5 CCRC)
• 2 Research Assistants
• 2 QA People:
• 1 Regulatory Person: 5 days to turn in regulatory documents to
IRB.
• 1 Contracts Person: 3-5 days to get contract signed
• 1 Recruitment Manager: RN, MBA in Marketing; creates ads, places
them in the media, tracks recruitment stats
• 1 Recruitment Coordinator maintains call center & patient
scheduling
• Board Certified Physicians in various therapeutic areas
• All staff certified in Human Subject Protection, CPR, HazMat/IATA
& HIPPA trained
• The American Lung Association Smoking Cessation Leader Training
Program
INVESTIGATORS
Nathan Segall, MD, CPI
Board Certified Internal Medicine
Board Certified Pediatric & Adult Allergy & Immunology
Gary Vogin, MD,
CPI
Internal Medicine
Board Certified Internal Medicine
